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http://www.biomedcentral.com/1756-0500/6/529CASE REPORT Open AccessCandida albicans lumbar spondylodiscitis in an
intravenous drug user: a case report
Chang-Hua Chen1,2, Wei Liang Chen3 and Hua-Cheng Yen4*Abstract
Background: Spondylodiscitis leads to debility, and few data exist on Candida spondylodiscitis in patients with
intravenous drug use.
Case presentation: We present a case of Candida albicans lumbar spondylodiscitis in a patient with intravenous
drug use. This patient was treated with surgical debridement and 9 months of fluconazole therapy, and the
neurological deficits resolved completely. The infection did not recur clinically or radiologically during 9 months of
follow-up.
Conclusion: Although Candida albicans lumbar spondylodiscitis is rare, Candida should be suspected as a causative
pathogen in patients with intravenous drug use except for Staphylococcus aureus, Pseudomonas aeruginosa, and
Mycobacterium tuberculosis. As soon as Candida albicans lumbar spondylodiscitis is suspected, magnetic resonance
imaging and percutaneous biopsy should be performed. Surgical intervention combined with treatment with
antifungal medications can successfully eradicate the infection and resolve the neurological deficits.
Keywords: Candida albicans, Lumbar spondylodiscitis, Spine, Vertebral osteomyelitis, Fungal infectionBackground
Spondylodiscitis is a rare disease accounting for 2–7% of
all cases of pyogenic osteomyelitis, with incidence vary-
ing from 1 per 100,000/year to 1 per 250,000/year [1,2].
However, the incidence of spondylodiscitis is rising be-
cause of longer life expectancy and more patients with
chronic debilitating disease, use of immunosuppressive
therapy, increasing use of indwelling devices, and spinal
surgery [3-5].
The first patient with fungal Monilia psilosis osteo-
myelitis was reported by Connor in 1928 [6], and there
was no report of Candida osteomyelitis in the literature
until 1970 [7]. A study by Gathe et al. showed that ap-
proximately 60% of cases of Candida osteomyelitis occur
in the spine [8]. Few data exist on Candida infection in
patients with intravenous drug use (IVDU) [9-11]. We
report on a case of Candida albicans lumbar spondylo-
discitis (CaLS) in a patient with IVDU, including the
clinical presentation, radiological findings, and outcome* Correspondence: 90211@cch.org.tw
4Department of Neurosurgery, Changhua Christian Hospital, Changhua,
Taiwan
Full list of author information is available at the end of the article
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reproduction in any medium, provided the orof combined surgical and medical treatment after
9 months of follow-up.
Case Presentation
A 41-year-old man with a history of IVDU with injection
of heroin initially presented to our clinic with a 3-month
history of lower back pain radiating to the lower limbs
bilaterally. Findings on neurological examination were
normal, and he was treated with oral non-steroidal anti-
inflammatory drugs. Three months later, he developed
myelopathic symptoms with weakness of both lower
limbs and severe back pain and presented to the neuro-
surgery clinic of our institute. Magnetic resonance im-
aging (MRI) of the lumbar spine showed diffuse bone
marrow infiltration plus endplate erosion level at L3 and
L4 characterized by low signal intensity on a T1-weighted
image and high signal intensity on a T2-weighted image,
with enhancement in affected bodies and cystic enhanced
lesions in the epidural and paraspinal regions after ad-
ministration of gadolinium (Figure 1). Radiologically,
pyogenic discitis, vertebral osteomyelitis, and epidural
and paraspinal abscesses had to be considered. The patient
was treated with oral non-steroidal anti-inflammatory
drugs at the clinic. On examination, there was generalizedtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Magnetic resonance imaging of the lumbar spine showed diffuse bone marrow infiltration plus endplate erosion level at L3
and L4. (a, b, and c) Magnetic resonance imaging (MRI) of the lumbar spine showed diffuse bone marrow infiltration plus endplate erosion level
at L3 and L4 characterized by low signal intensity on the T1-weighted image and high signal intensity on the T2-weighted image, with
enhancement in affected bodies and cystic enhanced lesions in epidural and paraspinal regions after administration of gadolinium.
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myelopathic signs in the lower extremities. The initial
laboratory findings revealed an elevated erythrocyte sedi-
mentation rate (ESR) (98 mm/hr; normal range, <10 mm/hr)
and anemia (12.3 g/dL; normal range, 14–17 g/dL). How-
ever, the results of other laboratory tests were within nor-
mal limits, including the white blood cell count (12,500
cells/mm3).
Radiography of the lumbar spine revealed spondylosis
of the lumbar spine with osteophyte formation and de-
crease disc height at L3–4. The patient underwent sur-
gery for symptomatic relief; left laminotomy over L3,
discectomy over L3–4 under a microscope, and debride-
ment of the disc and endplate were performed and
showed necrotic debris and fluid accumulation in the
L4–5 disc and endplates as well as a disc bulging over
the L3–4 level. The patient was treated empirically with
intravenous cefuroxime and gentamycin until candidal
infection was confirmed 3 days later. The clinical diagno-
sis was CaLS, and the patient was subsequently treated
with intravenous fluconazole 400 mg/day for 6 weeks and
then oral fluconazole 300 mg/day for another 3 months.
Nine months later, the patient’s ESR was 8 mm/hr; he had
recovered from his neurological deficit with complete
return of motor function in the lower limbs and was walk-
ing normally, and the motor weakness and pain in his legs
had resolved completely. Serial follow-up radiographs
after surgery and MRI showed significant shrinkage of
the vertebral osteomyelitis, discitis, and paraspinal ab-
scesses (Figure 2), although there were still abnormal
signal and enhanced lesions in the disc adjacent to the af-
fected vertebral bodies. The patient recovered very well
during the 9-month follow-up period and does not have
human immunodeficiency virus infection.
This is the first report of CaLS in a patient with IVDU.
Although Candida species are low-virulence organisms
that inhabit the skin and mucous membrane of humans,the incidence of disseminated and deep-seated Candida
infections in patients with IVDU is increasing [9-13]. A
new pattern of spondylodiscitis in IVDU is emerging,
characterized by more frequent unusual pathogen involve-
ment, a severe clinical course, and a need for surgery. Our
patient was treated with surgical debridement and anti-
fungal medications.
Because fungal infection has been rarely suggested as a
cause of vertebral osteomyelitis [14], we conducted an
evidence-based literature review (Table 1) with the key-
words “vertebral osteomyelitis”, “fungus”, “spondylodiscitis”,
“spine infection”, “fungal spondylitis”, and “fungal spinal
osteomyelitis”. Sixty-one patients with fungal vertebral
osteomyelitis were reported worldwide (Table 1) [8-13].
Men were more likely to have fungal vertebral osteo-
myelitis than women, usually around middle age. The
most common clinical presentations include local pain,
leg weakness, and paraesthesias of the lower extremities.
The involved sites of the spine included the cervical spine
in two cases, the thoracic spine in seven cases, and the
lumbar spine in 52 cases. The pathogens included
Candida albicans (21), Candida tropicalis (6), Aspergillus
fumigatus (6), Blastoschizomyces capitatus (6), Candida
parapsilosis (5), Pseudallescheria boydii (2), Nattrassia
mangiferae (2), Rhizopus rhizopodiformis (2), Scedosporium
apiospermum (2), Candida glabrata (2), Coccidioides
immitis (1),Trichosporon asahii (1), Scedosporium prolificans
(1), and Blastoschizomyces dermatitidis (1). Combined surgi-
cal intervention and antifungal therapy has been used
since the 1980s; overall, of the 61 patients, five died, two
experienced a relapse, and 54 patients recovered well.
There are no non-invasive diagnostic tests or typical
radiological findings in CaLS. Reports by Waldvogel and
Gathe showed that the delay in diagnosis between the on-
set of symptoms and the diagnosis of CaLS ranges from
1 month to several years, with an average of 3.3 months
[7]. Symptoms such as low-grade fever, malaise, and
Figure 2 Magnetic resonance imaging showed significant shrinkage of the vertebral osteomyelitis, discitis, and paraspinal abscesses.
(a and b) Magnetic resonance imaging (MRI) showed significant shrinkage of the vertebral osteomyelitis, discitis, and paraspinal abscesses,
although there were still abnormal signals and enhanced lesions in the disc adjacent to the affected vertebral bodies.
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lia, and elevated ESR are also non-specific, representing a
chronic inflammatory process, although a markedly ele-
vated ESR is suspicious of infection.
Candida spondylodiscitis usually involves the interver-
tebral disc space with narrowing of the disc cartilage,
causing destruction and lysis of the vertebral endplates
and underlying vertebral bone [8]. The findings on MRI
include an absence of disc hyperintensity and preserva-
tion of the internuclear cleft on T2-weighted images in
addition to increased signal intensity on gadolinium-
enhanced T1-weighted images and early disc destruction
and paraspinal abscesses [15]. The delay of antifungal
medical or surgical treatment in our case allowed us to
evaluate the natural course of the disease. Candida affects
the spinal segments probably through hematogenous dis-
semination, and once a focus develops in the vertebral
body, it continues an indolent course [12]. In our case,
vertebral collapse, psoas abscess formation, and neuro-
logical deficits became apparent within 3 months of the
onset of symptoms. The reasons for delayed suspicion
and diagnosis in our case included a delay in presen-
tation and a delay of investigation. A high index of
suspicion and immediate MRI would have confirmed
the pathologic lesions before vertebral collapse and
neurological compromise developed. As soon as lum-
bar spondylodiscitis is suspected, MRI and percutan-
eous biopsy should be performed, followed by medical
therapy. This may halt the progression of bony de-
struction and prevent the need for surgical treatment
[16]. Surgery is primarily indicated for failure of or
relapse after conservative treatment, significant spinal
collapse, and neurological deficits [17].
The management of patients with CaLS includes con-
servative treatment with biopsy, medical therapy, and bed
rest; posterior surgical stabilization and transpedicularbiopsy with or without fusion; or anterior debridement of
the abscesses, tissue diagnosis, and fusion combined with
posterior stabilization. Some investigators have recom-
mended primary reconstruction for all pyogenic infections
of the spine to maximize eradication of the infection [18],
and others have recommended surgery to aid in diagnosis
as well as decompression and stabilization of the spine
at the same time [19]. Combined debridement and
treatment with an antifungal agent was performed in
this case because there is controversy regarding the
use of instrumentation in the presence of infection,
and in this case the infection was successfully eradi-
cated and the neurological deficits were resolved.
Conclusions
Although CaLS is rare, Candida should be suspected as
a causative pathogen in patients with IVDU except for
Staphylococcus aureus, Pseudomonas aeruginosa, and
Mycobacterium tuberculosis. Without adequate treat-
ment, the disease is progressive and leads to vertebral
destruction and spinal cord and neural compression.
Early recognition of CaLS may be difficulty until the
patient either develops back pain with symptoms of
impending cord compression or develops various grades
of neurological deficits. As soon as CaLS is suspected,
MRI and percutaneous biopsy should be performed,
followed by medical therapy. This may halt the progres-
sion of bony destruction and prevent the need for surgery.
However, if vertebral collapse and spinal cord compres-
sion occurs, surgical intervention combined with antifun-
gal therapy can successfully eradicate the infection and
resolve the neurological deficits.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompanying
Table 1 Evidence-based literature review for fungal vertebral osteomyelitis
Year of publication/country/
number of patients/age (y)/sex
Clinical
symptoms








1980/Pennsylvania, USA/1/67/F Backache Acute myelomonocytic
leukemia







carcinoma of the lung
Aspergillus fumigatus Thoracic spine AmB + 5-FC/6 wk Died Barnwell PA,
et al. 1985
1982/NM/2/45–61/M Backache Previous lumbar
laminectomies (2)
Aspergillus fumigatus (2) Lumbar spine (2) Combination of surgical
debridement (2) and antifungal
therapy (2) (AmB)/NM
Survived/no ND Tack KJ, et al.
1982
1983/Oregon, USA/3/57–44/M Backache Previous L4–5
laminectomy and
discectomy
Candida albicans (3) Lumbar spine A combination of surgical
debridement (3) and antifungal
therapy (3) (AmB + FLU)/total 12
mo
Survived/no ND Mawk JR,
et al. 1983
1987/Washington, USA/1/44/M Backache Back trauma and
previous spinal surgery
Candida parapsilosis Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB)/NM
Survived/no ND Friedman BC,
et al. 1987
1987/Texas, USA/1/64/M Backache Back trauma and
previous spinal surgery
Candida parapsilosis Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB)/NM
Survived/no ND Gathe GC,
et al. 1987
1991/Netherlands/1/46/M Backache Previous disc surgery at
L4–5 for a herniated
nucleus pulposus










1994/Italy/1/14/F Backache ALL Blastoschizomyces capitatus Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB + ITR)/2 mo
Survived/no ND D'Antonio D,
et al. 1994
1994/Missouri, USA/1/36/F Backache Previous cavitary lung
infection with
Blastomyces dermatitidis
Blastomyces dermatitidis Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB to ITR)/40 days to
6 mo
Survived/no ND Lagging LM,
et al. 1994
1997/Australia/1/NM/NM NM Acute myeloid leukemia Pseudallescheria boydii NM Surgical debridement and
antifungal therapy
NM Gatto J, et al.
1997




ALL Blastoschizomyces capitatus Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB + FLU)/1 to 5 mo

































A combination of rgical
debridement and tifungal
therapy (AmB, FLU wk, 6 mo







Candida species Cervical spine A combination of rgical
debridement and tifungal
therapy (AmB, NM 0 days,
3 mo
Survived/no ND Wang and
Lee 2001
2001/New York,
USA/19–64/2 M, 1 F
Backache After artificial nail use
(3)
Candida albicans (3) Lumbar spine (3) A combination of rgical
debridement and tifungal










USA/11/78–28/8 M, 3 F
Omit DM (2), corticosteroid
use (4), chemotherapy










A combination of rgical
debridement and tifungal
therapy (AmB bas






2002/Ohio, USA/1/NM/NM Upper back
pain ( 4 mo)




2002/Lebanon/1/65/M Backache DM Candida albicans Thoracic spine,
with cord
compression
Surgical debridem t and
antifungal therapy LU)/NM
Survived/no ND El-Zaatari MM,
et al. 2002
2003/Switzerland/3/NM/NM Backache NM Candida albicans (2), Candida
tropicalis (1)
Lumbar spine (3),
2 with a spinal
epidural abscess
Surgical debridem t (3) and
antifungal therapy mB + FLU,
AmB alone, AmB + LU + ITR)
Survived/no ND Garbino J,
et al. 2003
2003/Spain/3/72–81/3 M Backache DM (2),
immunosuppression (2),
use of central venous
catheters (3), antibiotic
use (2), use of
parenteral nutrition (2)
Candida albicans (1), Candida
glabrata (1), Candida
parapsilosis (1)
Lumbar spine Surgical debridem t (3) and
antifungal therapy LU (2)/NM,
AmB + 5-FC (1)/NM
2 cured, 1 relapse Rodriguez D,
et al. 2003
2004/Taiwan/1/6/F Jaw pain ALL Blastoschizomyces capitatus Lumbar spine A combination of rgical
debridement and tifungal
therapy (ITR)/5 mo
Survived/no ND Cheung MY,
et al. 1999
2004/Italy/1/50/F Backache L4–5 previous
microdiscectomy
Aspergillus fumigatus Lumbar spine A combination of rgical
debridement and tifungal
therapy (ITR)/3 mo
Survived/no ND Lenzi J, et al.
2004
2004/Austria/1/62/M Backache Recipient of cadaveric
kidney transplantation
Nattrassia mangiferae Lumbar spine A combination of rgical
debridement and tifungal
therapy (AmB + VO )/NM
Died Willinger B,
et al. 2004
2004/Spain/1/37/M Backache ALL Blastoschizomyces capitatus Lumbar spine A combination of rgical
debridement and tifungal
therapy (ITR)/220 d s




















































Table 1 Evidence-based literature review for fungal vertebral osteomyelitis (Continued)
2006/Taiwan/1/57/M Backache Previous disc puncture
and previous radio-
frequency nucleoplasty
Rhizopus rhizopodiformis Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB to FLU)/ 8 wk
to 3 wk
Survived/no ND;




Kingdom/3/31–70/2 F, 1 M
Backache Nil Candida species Cervical spine (1),
thoracic spine (1),
lumbar spine (1)
A combination of surgical
debridement and antifungal
therapy (AmB + FLU)/14 days +
3 mo (1), 14 days + 10 wk (1),
12 wk (1)
Survived/no ND Khazim RM,
et al. 2006
2008/Turkey/1/63/M Backache Colon adenocarcinoma Blastoschizomyces capitatus Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB to ITR)/40 days
to 4 mo
Survived/no ND Celik AD,
et al. 2009
2008/Korea/1/42/F Backache Previous laminectomy
and discectomy
Trichosporon asahii Lumbar spine A combination of surgical
debridement and antifungal
therapy (FLU)/5 mo
Survived/no ND Kim KW,
et al. 2008
2008/Japan/1/14/M Backache Acute myeloid leukemia Blastoschizomyces capitatus Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB + VOR)/6 mo
Survived/no ND Yoshihara T,
et al. 2004
2008/New York, USA/1/43/M Backache Near-drowning Scedosporium apiospermum Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB + VOR, VOR)/
40 days to 12 mo
Survived/no ND Mesfin FB,
et al. 2008
2009/Spain/1/62/F Backache None Scedosporium prolificans Lumbar spine A combination of surgical
debridement and antifungal
therapy (AmB + VOR)/6 wk, 11
mo
Survived/no ND Garcia-Vidal C,
et al. 2009




use of central venous
catheters (2)
Candida albicans (3), Candida





antifungal therapy (6/6) (AmB
alone/12 wk then AmB + FLU/12
wk (1); FLU alone/9–36 wk (3);







None Candida albicans (1) Lumbar spine FLU/6 mo Survived/no ND This case
Abbreviations: ALL = acute lymphoblastic leukemia; AmB = amphotericin B; DM = diabetes mellitus; F = female; 5-FC = 5-fluorocytosine; FLU = fluconazole; ITR = itraconazole; M =male; ND = neurological deficit;
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